Roche
-5.53%

Pharma / Pharmaceuticals and Healthcare

Info

Overview Core Facts Blog Ratings

Analytics

Company Q&A Industry Q&A Competitors Stock Swings SWOT PEST Porter's Five Forces Score Positive Risks Revenue Segmentation

Financials

Income Statement Balance Sheet Cash Flow Statement

Ratios

Financial Ratios Financial Growth Enterprise Value Key Metrics Dividends

Tools

Due Diligence

Resources

News Clusters SEC Filings Stock Split History Press Releases Insider Trades Owner Earnings Earnings Calendar Web Reports

Core Facts

CEO	Dr. Thomas Schinecker
Employees	103249
Phone	41 61 688 11 11
Address	Konzern Hauptsitz Basel 04070 CH
IPO Date	2003-08-20
Average Volumes	3316585
Market Cap	244.299 bil USD
Div >7% since	N/A
Web	https://www.roche.com
ISIN	CH0012032048
NASDAQ ticker	RHHBY
News on YouTube	YouTube
SEC	'Roche' on SEC
Reports	'Roche' Reports
CUSIP	771195104
	EXECUTIVES
	Dr. Thomas Schinecker Chief Executive Officer
	Dr. James H. Sabry M.D., Ph.D. Global Head of Pharma Partnering
	Paulo Fontoura Head of Neuroscience Clinical Development
	Dr. Severin Schwan Ph.D. Executive Chairman
	Mr. William N. Anderson Chief Executive Officer of Roche Pharmaceuticals
	Dr. Paulo Fontoura M.D., Ph.D. Head of Neuroscience Clinical Development
	Dr. Johannes Carolus Clevers M.D., Ph.D. Head of Roche Pharma Research & Early Development
	Ms. Claudia Bockstiegel General Counsel
	Dr. Alan Hippe Chief Financial & Information Officer
	Ms. Pascale Schmidt Chief Compliance Officer
	Dr. Alan Hippe Chief Financial Officer
	Dr. Nicolas Dunant Head of Group Media Relations
	Ms. Pascale Schmidt Chief Compliance Officer
	Mr. Boris L. Zaitra Head of Corporate Business Development
	Dr. Bruno Eschli Head of Investor Relations
	Mr. Boris L. Zaitra Head of Corporate Business Development
	Ms. Barbara Schadler Head of Group Communications
	Ms. Cristina A. Wilbur Chief People Officer
	Ms. Cristina A. Wilbur Chief People Officer
	Ms. Barbara Schadler Head of Group Communications
	Dr. Bruno Eschli Head of Investor Relations
	Mr. Sascha Fauser Global Head of Ophthalmology Roche pRED
	Mr. Bryn Richard Roberts Global Head of Operations & Center Head Roche Pharmaceutical Research and Early Development
	Mr. Azad Bonni Global Head of pRED Neuroscience & Rare Diseases
	Sushil Patel Franchise Head Oncology
	Chris Brittain Global Head of Ophthalmology Product Development & Vice President
	Dr. Aviv Regev Ph.D. Head of Genentech Research & Early Development (gRED)
	Cristin Hubbard Senior Vice President of Immunology, Infectious Disease & Ophthalmology, Global Product Strategy
	Dr. Thomas Schinecker Group Chief Executive Officer
	Ms. Claudia Bockstiegel General Counsel
	Dr. Nicolas Dunant Head of Group Media Relations
	Dr. Severin Schwan Ph.D. Executive Chairman

What is special about us?

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

This feature is only available for users with Insider or Visionary license. Please, signup or login.